Traders sold shares of Express Scripts Holding Co. (NASDAQ:ESRX) on strength during trading hours on Tuesday. $63.86 million flowed into the stock on the tick-up and $184.92 million flowed out of the stock on the tick-down, for a money net flow of $121.06 million out of the stock. Of all equities tracked, Express Scripts Holding had the 0th highest net out-flow for the day. Express Scripts Holding traded up $0.81 for the day and closed at $73.12

Several research analysts recently weighed in on the company. Credit Suisse Group AG reissued a “buy” rating on shares of Express Scripts Holding in a research report on Saturday, June 4th. Zacks Investment Research raised Express Scripts Holding from a “hold” rating to a “buy” rating and set a $81.00 price target on the stock in a research report on Thursday, May 5th. Barclays PLC upped their price target on Express Scripts Holding from $85.00 to $87.00 and gave the company an “overweight” rating in a research report on Wednesday, July 27th. Mizuho upped their price target on Express Scripts Holding from $77.00 to $82.00 and gave the company a “neutral” rating in a research report on Tuesday, August 2nd. Finally, Wedbush reissued a “neutral” rating on shares of Express Scripts Holding in a research report on Wednesday, June 1st. Three equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and eight have given a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $81.26.

The stock has a market capitalization of $46.23 billion and a PE ratio of 18.12. The company’s 50-day moving average is $76.72 and its 200-day moving average is $73.54.

Express Scripts Holding (NASDAQ:ESRX) last announced its quarterly earnings data on Monday, July 25th. The company reported $1.57 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $1.57. The company earned $25.20 billion during the quarter, compared to the consensus estimate of $25.42 billion. During the same quarter in the previous year, the business earned $1.44 EPS. Express Scripts Holding’s revenue was down .9% on a year-over-year basis. Equities analysts expect that Express Scripts Holding Co. will post $6.38 earnings per share for the current year.

A number of institutional investors have bought and sold shares of the company. Wafra Investment Advisory Group Inc. NY boosted its position in Express Scripts Holding by 975.2% in the fourth quarter. Wafra Investment Advisory Group Inc. NY now owns 165,049 shares of the company’s stock worth $14,427,000 after buying an additional 149,699 shares during the last quarter. Schwab Charles Investment Management Inc. boosted its stake in shares of Express Scripts Holding by 12.2% in the fourth quarter. Schwab Charles Investment Management Inc. now owns 2,270,630 shares of the company’s stock worth $198,476,000 after buying an additional 246,358 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. boosted its stake in shares of Express Scripts Holding by 8.3% in the fourth quarter. Connor Clark & Lunn Investment Management Ltd. now owns 209,673 shares of the company’s stock worth $18,328,000 after buying an additional 16,000 shares in the last quarter. Calvert Investment Management Inc. purchased a new stake in shares of Express Scripts Holding during the fourth quarter worth about $3,110,000. Finally, American International Group Inc. boosted its stake in shares of Express Scripts Holding by 2.6% in the fourth quarter. American International Group Inc. now owns 372,766 shares of the company’s stock worth $32,583,000 after buying an additional 9,278 shares in the last quarter.

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.